The health and welfare of animals is at the heart of a thriving and sustainable food chain. We are investing in new animal healthcare technologies to solve major production challenges in aquaculture and agriculture.

We have recently invested £16 million expanding and upgrading our UK vaccine manufacturing facility. The new 2,500-square-meter facility enables a seamless transition from R&D through to production. 

Benchmark Vaccines Braintree Play the video "Learn more about our Animal Health services" Learn more about our Animal Health services
Our locations around the world give us first-hand knowledge of emerging health issues in key aquaculture regions, permitting more effective diagnosis, treatment and management advice.
Benchmark-Locations-Divisions

Building our technology platform

Our animal health pipeline includes a suite of vaccines and health solutions. The technologies we develop can easily be transferred across species, maximising our impact across the aquaculture, agriculture and animal health care sectors.

Health products

Our product development team works alongside commercial experts to identify the challenges facing our partners and clients. Our in-house trial units and manufacturing facilities allow us to overcome bottlenecks in development and efficiently progress products through to market.

Improving and promoting the health and welfare of animals is core to our work.
Fish-Vet-Group-Asia-Don-Farm-Visit

Manufacturing firepower

With over 25 years’ experience manufacturing aquaculture vaccines, we can accommodate contract manufacturing for our partners as well as our own increasing product pipeline.

We have recently expanded capacity at our UK vaccine manufacturing facility. The new £16 million 2,500-square-meter facility enables a seamless transition from R&D to production and improved efficiency and flexibility combining both conventional and recombinant vaccines, including Virus Like Particles (VLP).

2013 05 Bvl 75
"Our focus is on exploring and utilising the most powerful and effective vaccine science and technology in order to efficiently manufacture innovative products" Bob Long, Managing Director
Benchmark Vaccines LTD

Our Other Divisions